Dermapharm Holding SE invests in family-owned Austrian pharmaceutical company Montavit - Marketscreener.com
| ATS Stock | EUR 17.52 0.10 0.57% |
Under 50% of AT S's traders are presently thinking to get in. The analysis of current outlook of investing in AT S Austria suggests that some traders are interested regarding AT S's prospects. AT S's investing sentiment shows overall attitude of investors towards AT S Austria.
ATS |
Dermapharm Holding SE invests in family-owned Austrian pharmaceutical company Montavit Marketscreener.com
Read at news.google.com
 |
AT S Fundamental Analysis
We analyze AT S's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of AT S using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of AT S based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Shares Owned By Institutions
Shares Owned By Institutions Comparative Analysis
AT S is currently under evaluation in shares owned by institutions category among its peers. Shares Owned by Institutions show the percentage of the outstanding shares of stock issued by a company that is currently owned by other institutions such as asset management firms, hedge funds, or investment banks. Many investors like investing in companies with a large percentage of the firm owned by institutions because they believe that larger firms such as banks, pension funds, and mutual funds, will invest when they think that good things are going to happen.
AT S Austria Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with AT S stock to make a market-neutral strategy. Peer analysis of AT S could also be used in its relative valuation, which is a method of valuing AT S by comparing valuation metrics with similar companies.
Peers
AT S Related Equities
| WIE | Wienerberger | 2.23 | ||||
| VOE | Voestalpine | 0.34 | ||||
| ANDR | Andritz AG | 0.33 | ||||
| LNZ | Lenzing Aktiengesellscha | 0.54 | ||||
| OMV | OMV Aktiengesellscha | 1.10 |
Complementary Tools for ATS Stock analysis
When running AT S's price analysis, check to measure AT S's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AT S is operating at the current time. Most of AT S's value examination focuses on studying past and present price action to predict the probability of AT S's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AT S's price. Additionally, you may evaluate how the addition of AT S to your portfolios can decrease your overall portfolio volatility.
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |